|
Aug 13
|
CHE Q2 Deep Dive: Margin Pressure, Medicare Cap Challenges, and Strategic Repositioning
|
|
Aug 13
|
5 Insightful Analyst Questions From Chemed’s Q2 Earnings Call
|
|
Aug 11
|
Q2 Earnings Outperformers: Chemed (NYSE:CHE) And The Rest Of The Senior Health, Home Health & Hospice Stocks
|
|
Aug 2
|
Earnings Miss: Chemed Corporation Missed EPS By 23% And Analysts Are Revising Their Forecasts
|
|
Aug 1
|
Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents
|
|
Jul 31
|
Chemed Second Quarter 2025 Earnings: EPS Misses Expectations
|
|
Jul 31
|
Chemed Corp (CHE) Q2 2025 Earnings Call Highlights: Navigating Challenges and Strategic Growth
|
|
Jul 30
|
VITAS® Healthcare Announces CEO Transition and Appointment of New Chief Executive Officer
|
|
Jul 30
|
Why Chemed Stock Is Plummeting Today
|
|
Jul 30
|
Why Chemed (CHE) Stock Is Trading Lower Today
|
|
Jul 29
|
Chemed’s (NYSE:CHE) Q2 Earnings Results: Revenue In Line With Expectations But Stock Drops
|
|
Jul 29
|
Chemed (CHE) Q2 Earnings Miss Estimates
|
|
Jul 29
|
Chemed: Q2 Earnings Snapshot
|
|
Jul 29
|
Chemed Reports Second-Quarter 2025 Results and Announces Executive Management Departure
|
|
Jul 28
|
ASTH vs. CHE: Which Stock Is the Better Value Option?
|
|
Jul 28
|
Chemed (CHE) Q2 Earnings: What To Expect
|
|
Jul 27
|
Chemed updates 2025 forecast as Q1 revenue shows continued growth
|
|
Jul 24
|
Chemed Corporation (CHE): A Bull Case Theory
|
|
Jul 23
|
Chemed (CHE) Fell due to Concerns Over Potential Medicare Cap Limits
|
|
Jul 22
|
Analysts Estimate Chemed (CHE) to Report a Decline in Earnings: What to Look Out for
|